Dupixent®’s Positive Phase 3 Trial for COPD Spurs FDA Submission as Potential First Approved Biologic
The NOTUS trial, the second Phase 3 trial for Dupixent®, has reported a 34% reduction in chronic obstructive pulmonary disease (COPD) exacerbations, supporting previous...
Roche Broadens Hepatitis Diagnostic Portfolio for Enhanced Patient Monitoring and Diagnosis
Roche, a leader in diagnostic solutions, has launched Elecsys® HBeAg quant, a breakthrough immunoassay designed to diagnose and monitor hepatitis B (HBV) infection efficiently....
AWTTC Releases Annual Report 2022-2023 on Individual Patient Funding Request
The All Wales Therapeutics and Toxicology Centre (AWTTC) has released its annual report for the Individual Patient Funding Request (IPFR) in 2022-2023, showcasing the...
Embracing the Comprehensive Impact of Antibiotics
The value antibiotics bring often surpasses what traditional Health Technology Assessment (HTA) captures. The STEDI framework, focusing on Spectrum, Transmission, Enablement, Diversity, and Insurance,...
European Approval Secured by Vertex for Cystic Fibrosis Medicine
Vertex Pharmaceuticals achieved a significant milestone in July 2023 when the European Commission granted an expanded label for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, specifically for...
Denmark’s Nationwide Initiative: Introducing Telemedicine Solution for COPD
In November 2023, the Danish Regions revealed plans to initiate a nationwide telemedicine solution tailored for individuals grappling with severe chronic obstructive pulmonary disease...
European Commission Gives Nod to Initial Ovarian Cancer Therapy
The European Commission's (EC) recent approval of rucaparib marks a significant milestone in ovarian cancer treatment. This decision extends the use of rucaparib, a...
Insights on Digital Transformation: UCB CEO Jean-Christophe Tellier’s Perspective
UCB, a Belgian midcap in the pharmaceutical sector, has been deeply involved in an expansive digital transformation. Jean-Christophe Tellier, the CEO, detailed the company's...
NICE Advice: An Updated Support Service for Pharmaceutical and Health Tech Companies
NICE recently unveiled an updated support service, "NICE Advice" designed explicitly for pharmaceutical and health tech companies. This service aims to aid these entities...
Medtronic’s Fiscal 2024 Q2 Financial Performance Unveiled
Medtronic reported robust financial results for its second quarter of fiscal year 2024, marked by a 5.3% increase in revenue to $8.0 billion, driven...
